12.07.2015 Views

April 1, 2010, Home Health & Hospice Medicare A Newsline - CGS

April 1, 2010, Home Health & Hospice Medicare A Newsline - CGS

April 1, 2010, Home Health & Hospice Medicare A Newsline - CGS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Part B Drug CAP program be reinstituted sometime during CY <strong>2010</strong>, <strong>Medicare</strong> would again use thePart B drug CAP rate for pass-through drugs and biologicals if they are a part of the Part B drugCAP program, as required by the statute.In the CY <strong>2010</strong> OPPS/ASC final rule with comment period, it was stated that payments for drugsand biologicals based on ASPs will be updated on a quarterly basis as later quarter ASP submissionsbecome available. In cases where adjustments to payment rates are necessary based on the mostrecent ASP submissions, <strong>Medicare</strong> will incorporate changes to the payment rates in the <strong>April</strong> <strong>2010</strong>release of the OPPS Pricer. The updated payment rates, effective <strong>April</strong> 1, <strong>2010</strong>, will be included inthe <strong>April</strong> <strong>2010</strong> update of the OPPS Addendum A and Addendum B, which will be posted on theCMS Web site.b. Drugs and Biologicals with OPPS Pass-Through Status Effective <strong>April</strong> 1, <strong>2010</strong>Six drugs and biologicals have newly been granted OPPS pass-through status, effective <strong>April</strong> 1,<strong>2010</strong>. These items, along with their descriptors and APC assignments, are identified in Table 3below.Table 3—Drugs and Biologicals with New OPPS Pass-Through Status Effective <strong>April</strong> 1, <strong>2010</strong>HCPCSCodeLong Descriptor APC Status IndicatorEffective <strong>April</strong> 1, <strong>2010</strong>C9258 Injection, telavancin, 10 mg 9258 GC9259 Injection, pralatrexate, 1 mg 9259 GC9260 Injection, ofatumumab, 10 mg 9260 GC9261 Injection, ustekinumab, 1 mg 9261 GC9262 Fludarabine phosphate, oral, 1 mg 9262 GC9263 Injection, ecallantide, 1 mg 9263 Gc. Updated Payment Rate for HCPCS Code J9031 Effective January 1, 2009 through March 31,2009The payment rate for one HCPCS code was incorrect in the January 2009 OPPS Pricer. Thecorrected payment rate is listed in Table 4 below and has been installed in the <strong>April</strong> <strong>2010</strong> OPPSPricer, effective for services furnished on January 1, 2009, through implementation of the <strong>April</strong> 2009update.Table 4—Updated Payment Rate for HCPCS Code J9031 Effective January 1, 2009 through March31, 2009HCPCSCodeStatus Indicator APC Short DescriptorCorrectedPaymentRateCorrected MinimumUnadjustedCopaymentJ9031 K 0809 Bcg live intravesical vac $118.96 $23.79<strong>Home</strong> <strong>Health</strong> & <strong>Hospice</strong> <strong>April</strong> 1, <strong>2010</strong> 17<strong>Medicare</strong> A <strong>Newsline</strong> Vol. 17, No. 7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!